Hyundai Motor Co. and affiliate Kia Corp. posted a combined market share of a record 7 percent in Europe last year, rising from 6.7 percent in Europe in 2019.
However, in line with European market trends, their sales in Europe plunged 21 percent on-year to 841,520 vehicles.
Hyundai's sales plunged 25 percent on-year to 424,805 units, while Kia's dropped 17 percent to 416,715 units.
Hyundai sold over 100,000 units of its Kona subcompact SUV for the second straight year, while Kia duplicated the feat with its C'eed sporty wagon.
According to the European Automobile Manufacturers' Association (ACEA), they witnessed their largest annual drop in car demand in 2020 since its records began in 1990.
Overall vehicle sales in Europe plummeted 24 percent to 11.96 million units last year due to the pandemic.
New car sales declined for the third month in a row in December due to measures to restrict a second coronavirus wave.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



